Johnson & Johnson (JNJ) is around the top of the Drug Manufacturers - General industry according to InvestorsObserver. JNJ received an overall rating of 65, which means that it scores higher than 65 percent of all stocks. Johnson & Johnson also achieved a score of 86 in the Drug Manufacturers - General industry, putting it above 86 percent of Drug Manufacturers - General stocks. Drug Manufacturers - General is ranked 108 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 65 would rank higher than 65 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Johnson & Johnson Stock Today?
Johnson & Johnson (JNJ) stock is trading at $166.91 as of 2:48 PM on Thursday, Jun 10, a gain of $1.25, or 0.75% from the previous closing price of $165.66. The stock has traded between $165.95 and $167.58 so far today. Volume today is low. So far 3,330,705 shares have traded compared to average volume of 6,835,336 shares.